JACOBS LEVY EQUITY MANAGEMENT, INC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q1 2018$75,000
-41.9%
28,411
-23.0%
0.00%
-50.0%
Q4 2017$129,000
-46.2%
36,910
-22.3%
0.00%
-60.0%
Q3 2017$240,000
+17.6%
47,510
-50.0%
0.01%
+25.0%
Q4 2016$204,000
-53.8%
95,074
-31.6%
0.00%
-50.0%
Q3 2016$442,000
+215.7%
138,962
+176.1%
0.01%
+166.7%
Q2 2016$140,000
-15.2%
50,339
+19.8%
0.00%0.0%
Q1 2016$165,00042,0040.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders